top of page

Wrapping up the summer and looking ahead to biotech's post Labor Day news flow with NYSE's Eric Dimise from Kendall Square

  • blonca9
  • Aug 29, 2024
  • 1 min read

He discusses the sector's IPO activity YTD, what we might expect through the end of the year, and what types of companies have the best chances of getting an IPO done.




Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter

@BiotechTVHQ

  • LinkedIn

BiotechTV

  • Facebook

BiotechTVHQ

  • TikTok

@BiotechTV

  • Instagram

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Genezen_Logo_RGB.png

Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.

Learn more about Genezen

bottom of page